When was Frenova founded?

Frenova was founded in 2001 and raised its 1st funding round 25 years after it was founded.

Where is Frenova located?

Frenova is headquartered in Waltham, United States.

How many employees does Frenova have?

As of Jul 31, 2026, the latest employee count at Frenova is 76.

Is Frenova a funded company?

Frenova is a funded company, having raised a total of $***** in its 1st and only funding round, a Post IPO round on Apr 08, 2026.

When was the latest funding round of Frenova?

Frenova's latest funding was a $***** Post IPO round on Apr 08, 2026, with participation from 0 investor.

Where does Frenova rank among its competitors?

Frenova ranks 10th amongst 572 active competitors, of which 3 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Frenova, which secured $37.9K in Apr, 2026.

Who are the top competitors of Frenova?

Frenova's top competitors include PPD, Kayentis and Symphony Health. Among them, Frenova secured the most recent funding round in April, 2026.

Frenova - 2026 Company Profile, Funding & Competitors

Frenova is a public company based in Waltham (United States), founded in 2001. It operates as a Provider of site management, data analytics, and genomics research for clinical trials. Frenova has raised an undisclosed amount in funding. The company has 572 active competitors, including 3 funded and 24 that have exited. Its top competitors include companies like PPD, Kayentis and Symphony Health.

Company Details

Provider of site management, data analytics, and genomics research for clinical trials. It delivers a network of research sites and expertise to accelerate clinical trial initiation. The company facilitates patient enrollment for renal trials and studies of related conditions. It offers data analytics and licensing services, providing access to a longitudinal database in nephrology. The company strengthens clinical trials to advance science.

Key Metrics

Founded Year

2001

Location

Waltham, United States

Stage

Public

Latest Funding Round

Post IPO, Apr 08, 2026, $*****

Ranked

10^th among 572 active competitors

Employee Count

76 as on Jul 31, 2026

Similar Companies

PPD & 573 more

Exit Details

Public

View Frenova's full profile

Frenova is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Fresenius Medical Care Holdings, Inc. CIN: 1246335 , United States, Active	Mar 23, 1988	-	-	-

Frenova has raised funding over 1 round.

Here is the list of recent funding rounds of Frenova:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 08, 2026	6752338	Post IPO	5607793	4014043	6040133	4819109

Access funding benchmarks and valuations. Sign up today!

View details of Frenova's funding rounds and investors

Frenova's employee count trend

Frenova has 76 employees as of Jul 26. Here is Frenova's employee count trend over the years:

Uncover Frenova's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Frenova include PPD, Kayentis and Symphony Health. Here is the list of Top 10 competitors of Frenova, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PPD 1985, Wilmington (United States), Acquired	CRO providing diversified clinical development services	-	Hellman & Friedman, Thecarlylegroup.fr & 2 others	65/100
2nd	Kayentis 2003, Meylan (France), Series D	Provider of electronic clinical outcome assessment solutions for clinical trials	$36.2M	Extens, Seventure Partners & 5 others	58/100
3rd	Symphony Health 2012, Horsham (United States), Acquired	Provider of clinical research, consulting, and commercial services for healthcare sectors	-	Autonomy Ventures, STG	42/100
4th	Medicus Pharma 2008, Toronto (Canada), Public	Clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies in the biotechnology and life sciences industry	-	-	42/100
5th	H.U. Group Holdings 1950, Shinjuku (Japan), Public	Provider of clinical testing, diagnostics, and healthcare services. This entity offers a range of services encompassing laboratory testing and related services, in-vitro diagnostics, healthcare-related services, and research and development. Their activities include supporting research in clinical laboratory medicine, fostering technological advancements, and contributing to the overall progress of medical science and healthcare technology. They also engage in intellectual property activities and have initiatives addressing public health concerns.	-	-	39/100
6th	Volv Global 2017, Epalinges (Switzerland), Funding Raised	Provider of AI and machine learning solutions for healthcare insights	-	Seedlink	38/100
7th	Hangzhou Baicheng Pharmaceutical Technology 2011, Hangzhou (China), Public	Provider of comprehensive pharmaceutical research and development services across drug lifecycles	-	Paradise Silicon Valley Asset Management Group	35/100
8th	YD Biopharma 2004, Taipei (Taiwan), Unfunded	Provider of diagnostic and therapeutic technologies, focusing on exosome science and cancer detection	-	-	34/100
9th	IPHARMA 2012, Moscow (Russia), Unfunded	CRO focused on conducting all drug clinical trials	-	-	31/100
10th	Frenova 2001, Waltham (United States), Public	Provider of site management, data analytics, and genomics research for clinical trials	-	-	25/100